Flora Expands European Success with Thriving Partnership in Czech Republic and Slovakia
Flora Growth Corp. (NASDAQ: FLGC) has renewed sales orders with Mirfa s.r.o. for the Czech Republic and Slovakia markets, continuing a four-year partnership valued at approximately $500,000 annually. The company supplies JustCBD branded products, including gummies, tinctures, and oils through Just Brands UK's distribution network. The Czech CBD market reached $34 million in 2024, representing a significant growth opportunity in Europe's emerging cannabis markets. Mirfa specializes in CBD-infused products for humans and pets, focusing on sleep improvement, stress reduction, and pain relief solutions.
Flora Growth Corp. (NASDAQ: FLGC) ha rinnovato gli ordini di vendita con Mirfa s.r.o. per i mercati della Repubblica Ceca e della Slovacchia, continuando una partnership di quattro anni valutata circa 500.000 dollari all'anno. L'azienda fornisce prodotti a marchio JustCBD, inclusi gomitoli, tinture e oli, attraverso la rete di distribuzione di Just Brands UK. Il mercato CBD ceco ha raggiunto 34 milioni di dollari nel 2024, rappresentando un'opportunità di crescita significativa nei mercati emergenti della cannabis in Europa. Mirfa si specializza in prodotti infusi di CBD per umani e animali domestici, focalizzandosi sul miglioramento del sonno, la riduzione dello stress e le soluzioni per il sollievo dal dolore.
Flora Growth Corp. (NASDAQ: FLGC) ha renovado los pedidos de venta con Mirfa s.r.o. para los mercados de la República Checa y Eslovaquia, continuando una asociación de cuatro años valorada en aproximadamente 500,000 dólares anuales. La empresa suministra productos de la marca JustCBD, incluyendo gomitas, tinturas y aceites a través de la red de distribución de Just Brands UK. El mercado de CBD en Chequia alcanzó 34 millones de dólares en 2024, lo que representa una oportunidad de crecimiento significativa en los mercados emergentes de cannabis en Europa. Mirfa se especializa en productos infusionados con CBD para humanos y mascotas, centrándose en la mejora del sueño, la reducción del estrés y las soluciones para aliviar el dolor.
플로라 그로스 코퍼레이션(NASDAQ: FLGC)이 체코와 슬로바키아 시장을 위한 미르파 s.r.o.와 판매 주문을 갱신했습니다. 이는 약 연간 50만 달러의 가치를 지닌 4년 파트너십을 계속하는 것입니다. 회사는 Just Brands UK의 유통 네트워크를 통해 젤리, 팅크 및 오일과 같은 JustCBD 브랜드의 제품을 공급합니다. 체코 CBD 시장은 2024년 3400만 달러에 도달하여 유럽의 새로운 대마초 시장에서 상당한 성장 기회를 나타냅니다. 미르파는 인간과 반려동물용 CBD 함유 제품을 전문으로 하며, 수면 개선, 스트레스 감소 및 통증 완화 솔루션에 중점을 두고 있습니다.
Flora Growth Corp. (NASDAQ: FLGC) a renouvelé des commandes de vente avec Mirfa s.r.o. pour les marchés de la République tchèque et de la Slovaquie, poursuivant un partenariat de quatre ans évalué à environ 500 000 dollars par an. L'entreprise fournit des produits sous la marque JustCBD, y compris des bonbons gélifiés, des teintures et des huiles via le réseau de distribution de Just Brands UK. Le marché du CBD en Tchéquie a atteint 34 millions de dollars en 2024, représentant une opportunité de croissance significative sur les marchés émergents du cannabis en Europe. Mirfa se spécialise dans les produits au CBD pour les humains et les animaux de compagnie, en se concentrant sur l'amélioration du sommeil, la réduction du stress et les solutions pour soulager la douleur.
Flora Growth Corp. (NASDAQ: FLGC) hat Verkaufsbestellungen mit Mirfa s.r.o. für die Märkte der Tschechischen Republik und der Slowakei erneuert und setzt damit eine vierjährige Partnerschaft fort, die auf ungefähr 500.000 Dollar jährlich geschätzt wird. Das Unternehmen liefert Produkte der Marke JustCBD, einschließlich Gummibärchen, Tinkturen und Ölen über das Distributionsnetzwerk von Just Brands UK. Der tschechische CBD-Markt erreichte 2024 34 Millionen Dollar und stellt eine bedeutende Wachstumschance in den aufstrebenden Cannabis-Märkten Europas dar. Mirfa spezialisiert sich auf CBD-haltige Produkte für Menschen und Haustiere, mit Fokus auf Schlafverbesserung, Stressreduktion und Schmerzlinderungslösungen.
- Secured renewal of $500,000 annual sales orders for Czech Republic and Slovakia markets
- Established presence in Czech CBD market valued at $34 million
- Maintained successful four-year business relationship with key distributor
- None.
Insights
The
- Four-year proven track record with Mirfa
- Established distribution network through Just Brands UK
- Diversified product portfolio including gummies, tinctures and oils
Fort Lauderdale, Florida--(Newsfile Corp. - November 26, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce it has renewed its sales orders for the Czech Republic and Slovakia through one of Just Brands UK's largest customers, Mirfa s.r.o. ("Mirfa") This long-standing partnership, valued at total demand of approximately
This builds upon a strong four-year business relationship. Over this time, the collaboration has solidified Flora's position as a reliable supplier of high-quality products in the Czech and Slovakian markets. It leverages Flora's expertise in product innovation and compliance, coupled with Just Brands UK's distribution network, ensuring Flora's products reach consumers efficiently and effectively.
Clifford Starke, Chairman and Chief Executive Officer, noted: "our long-standing relationships in Europe are a testament to the strength of collaboration and mutual trust. Over the past four years, this partnership has been a part of our European strategy, allowing us to bring premium products to customers in the Czech Republic and Slovakia. We are proud of the value this relationship continues to deliver, both in terms of revenue and brand recognition."
The orders reflect the growing demand for Flora's product portfolio, including its renowned JustCBD line, which has resonated with consumers seeking trusted, high-quality products. The Czech Republic and Slovakia are among Europe's emerging cannabis markets, with increasing consumer acceptance and regulatory progress driving growth opportunities for innovative companies like Flora. According to Statista, the Czech CBD market reached
Mirfa is a Czech company specializing in CBD-infused products designed to enhance well-being for both humans and pets. Their offerings include CBD gummies aimed at improving sleep, reducing stress, and alleviating pain, as well as CBD treats formulated to promote calmness and comfort in dogs. It operates with a commitment to transparency, quality assurance, and customer satisfaction, ensuring that its products meet the highest standards of safety and efficacy. As part of its mission, the company is actively engaged in educating consumers about the benefits of CBD and providing accessible solutions for modern needs across the Czech Republic.
About Flora Growth Corp.
Flora Growth Corp.'s mission is to become the leading NASDAQ small-cap international cannabis company. Flora is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://justcbdstore.com/
https://www.vesselbrand.com/
https://justcbdstore.uk/
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231318
FAQ
What is the annual value of Flora Growth's (FLGC) partnership with Mirfa in Czech Republic and Slovakia?
What products does Flora Growth (FLGC) supply to the Czech and Slovak markets?
What is the size of the Czech CBD market where Flora Growth (FLGC) operates?
